These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4665554)

  • 1. [Disorders of the liver detoxicating function in 536 histologically diagnosed fatty liver patients].
    Korn U; Fischer R; Müting D
    Verh Dtsch Ges Inn Med; 1972; 78():1386-9. PubMed ID: 4665554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of fatty liver with essential phospholipids].
    Arendt R; Nowotny P; Teichmann W
    Z Gesamte Inn Med; 1970 Jul; 25(13):587-9. PubMed ID: 5523267
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of fatty liver].
    Müting D
    Clin Ter; 1974; 70(2):5-6. PubMed ID: 4411261
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesterolone in steatosis and cirrhosis of the liver.
    Figueroa RB
    Acta Hepatogastroenterol (Stuttg); 1973; 20(4):282-90. PubMed ID: 4760412
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormalities of serum monoamine oxidase in chronic liver disease.
    McEwen CM; Castell DO
    J Lab Clin Med; 1967 Jul; 70(1):36-47. PubMed ID: 6027096
    [No Abstract]   [Full Text] [Related]  

  • 6. [Regenerative tendencies in the alcoholic fatty liver under diet. Change in the dietary fat content].
    Irsigler K; Kryspin-Exner K; Mildschuh W
    Acta Hepatosplenol; 1970; 17(2):103-10. PubMed ID: 5524290
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis: role of leptin in pathogenesis and benefits of metformin in treatment.
    Kadayifçi A
    Am J Gastroenterol; 2003 Oct; 98(10):2330; author reply 2330-1. PubMed ID: 14572592
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
    Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes.
    Morita Y; Ueno T; Sasaki N; Tateishi Y; Nagata E; Kage M; Sata M
    Hepatogastroenterology; 2005; 52(65):1338-43. PubMed ID: 16201069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phospholipids (EPL) on the lipid contents of the serum and liver in white rats after a single dose of ethyl alcohol.
    Samochowiec L; Wojcicki J
    J Med; 1970; 1(5):299-303. PubMed ID: 5286528
    [No Abstract]   [Full Text] [Related]  

  • 11. Adiponectin: is it a novel treatment modality to alleviate liver injury in non-alcoholic fatty liver disease (NAFLD)?
    Aygun C; Kocaman O; Senturk O
    Med Hypotheses; 2008; 70(2):457-8. PubMed ID: 17656035
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolving trends in nonalcoholic fatty liver disease.
    Delgado JS
    Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on fatty liver, blood glucose and related factors in simple obese children].
    Zhang H; Li Y; Guan X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):336-7. PubMed ID: 11769636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease in children: a single center experience.
    A-Kader HH; Henderson J; Vanhoesen K; Ghishan F; Bhattacharyya A
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):799-802. PubMed ID: 18486560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the best indicator for evaluating treatment response in nonalcoholic fatty liver disease: histology or aminotransferase levels?
    Akyuz F; Demir K; Cevikbas U; Okten A
    J Gastroenterol Hepatol; 2005 Jan; 20(1):167-8. PubMed ID: 15610470
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperammonemia and Reye's syndrome.
    Kang ES; Gerald PS
    N Engl J Med; 1972 Jun; 286(22):1216-7. PubMed ID: 5021339
    [No Abstract]   [Full Text] [Related]  

  • 18. A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats.
    Patel K; Muir A; McHutchison JG; Patton HM
    Am J Gastroenterol; 2003 May; 98(5):952-5. PubMed ID: 12809813
    [No Abstract]   [Full Text] [Related]  

  • 19. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
    Angulo P; Alba LM; Petrovic LM; Adams LA; Lindor KD; Jensen MD
    J Hepatol; 2004 Dec; 41(6):943-9. PubMed ID: 15582127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total serum bile acid concentrations in dairy cows with fatty liver and liver failure.
    Rehage J; Qualmann K; Meier C; Stockhofe-Zurwieden N; Hoeltershinken M; Pohlenz J
    Dtsch Tierarztl Wochenschr; 1999 Jan; 106(1):26-9. PubMed ID: 10028757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.